To conclude, sarcopenia and frailty should be assessed according to a new definition of their conceptualand clinical realities. Impairment of the physical function in the absence of disability isdefinitively the link between both conditions. Thus, we can first opt for targeted clinical interventionsagainst disability; then, make both conditions not just concepts but part of our clinical implementations;finally, make both health conditions depend on an objective, clinically assessed andrelevant standard that would be definitely part and parcel of public health protocols. To reach thisgoal, it is necessary to include sarcopenia and frailty into a unique and wholly effective operationalconcept.